Category Archives: Drugs

The high price of Big Pharma greed

By Leena Menghaney, The Hindu | March 4, 2017 In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, … Continue reading

Posted in Biologics/Biosimilars, Drug prices, Uncategorized | Tagged , , | Leave a comment

MSF calls on Japan and South Korea to drop the harmful RCEP measures

Kobe, Japan/New Delhi 22 February 2017 As 16countries negotiating the Regional Comprehensive Economic Partnership (RCEP)agreement meet next week in Kobe, Japan, for the seventeenth round of negotiations, international medical humanitarian organisation Médecins Sans Frontières (MSF) is appealing tothe Japanese and South … Continue reading

Posted in Data Exclusivity, Drug prices, Generics, Patent Term Extension, Regional Comprehensive Economic Partnership, TRIPS, TRIPS plus, Uncategorized | Leave a comment

Pharma PSUs Are Not Ready To Die!

By Murali Neelakantan, BloombergQuintOpinion | February 7, 2017 The government’s decision to explore the strategic sale of Indian Drugs and Pharmaceuticals Ltd. and Bengal Chemicals – even as questions were asked of the move last week by parliamentarians including those from the BJP … Continue reading

Posted in Generics, Patent, Pricing, Uncategorized | Leave a comment

How charity is fuelling a superbug in India?

By Ruhi Khandar, The Ken The evil superbug is on the lookout for new hosts. The hero has the weapon, he can conquer it, but only if he is willing. The superbug is antibiotic-resistant bacteria, which causes multi-drug-resistant tuberculosis (MDR-TB), the … Continue reading

Posted in Compulsory Licensing, Drugs, Tuberculosis (TB), Uncategorized | Tagged , , | Leave a comment

Indian pharma industry fears tougher US stance on IP

Prices of patented drugs are lower in Canada, United Kingdom and Australia in comparison to the US By Aneesh Phadnis & Reuters| Published: Business Standard | february 1, 2017 Indian pharma industry is fearing a tougher US government stance on intellectual … Continue reading

Posted in Generics, IPR, Uncategorized, US pressure on India | Leave a comment

Poor countries allowed to import generic drugs – WTO

By Tom Miles, Reuters | January 23, 2017 Poor countries are allowed to import generic medicines, World Trade Organization (WTO) Director General Roberto Azevedo told Reuters on Monday, after the required two-thirds of members agreed a deal that has taken … Continue reading

Posted in Generics, TRIPS, Uncategorized, WTO | Leave a comment

U.S. Supreme Court agrees to hear dispute over biologic drug sales

By Andrew Chung, Reuters The U.S. Supreme Court on Friday agreed to hear a dispute over whether companies that make copycat versions of biologic drugs must wait six months after winning federal approval to begin selling them. The justices will … Continue reading

Posted in Biologics/Biosimilars, Generics, Uncategorized | Leave a comment